wiscoglobal

Founded: 2024 • Age: 2 yrs
Provides innovative pharmaceutical solutions through licensing, trading, and global sourcing.

About wiscoglobal

wiscoglobal is a Healthcare company founded in 2024. It provides innovative pharmaceutical solutions through licensing, trading, and global sourcing. It operates on a B2B and Licensing model. Its Indian entity Wishco Global Private Limited reported revenue of β‚Ή85.2 Lakh. wiscoglobal offers products and services including Azicocin 500, Ciprowish, CoughCure, Flucare, and Carbowish Injection. Its focus areas include Pharmaceuticals, Therapeutic Areas, Antiviral and Oncology.

Company details

Wishco Pharma, a division of Wishco Global Pvt. Ltd., specializes in developing and distributing high-quality pharmaceuticals that meet international standards. The company focuses on therapeutic areas like antiviral and cardiovascular drugs, partnering with global innovators for in-licensing and out-licensing. Based in Bikaner, India, it facilitates trading, global sourcing, and tenders to address healthcare needs worldwide, ensuring affordable and reliable solutions for providers and patients.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website wishcoglobal.com
  • Social LinkedIn Instagram
  • Legal Name Wishco Global Pvt. Ltd.
  • Date of Incorporation 27 Sep, 2024
  • Jurisdiction Bikaner, Rajasthan, India
Key Metrics
  • Indian entity revenue
    ₹85.2 Lakh

    FY 2025

  • Indian entity net profit
    ₹55,431

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹76,700

    FY 2025 · 1% margin

Products & Services of wiscoglobal

wiscoglobal offers a comprehensive portfolio of products and services, including Azicocin 500, Ciprowish, CoughCure, Flucare, and Carbowish Injection.

Azicocin 500
Antibiotic

Antibiotic medication for treating bacterial infections effectively.

Ciprowish
Antibiotic

Antibiotic used to combat various infections and promote healing.

CoughCure
Respiratory

Remedy for alleviating cough and related respiratory symptoms.

Flucare
Antifungal

Treatment for fungal infections with targeted precision.

Carbowish Injection
Oncology

Injection for cancer treatment to support patient recovery.

Board of directors of Wishco Global Private Limited (wiscoglobal)

Wishco Global Private Limited is the primary company behind wiscoglobal. The board of Wishco Global Private Limited currently have 2 directors; the longest-serving is Vaibhav Agarwal, appointed in 2024. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Vaibhav Agarwal
DIN 10790953
Director27 Sep 20242 yrs 1 moWishco Global Private Limited
Kanti Kamal Agarwal
DIN 10790954
Director27 Sep 20242 yrs 1 moWishco Global Private Limited

Financials of wiscoglobal

Figures of Wishco Global Private Limited, the primary company behind wiscoglobal, for FY 2025. Revenue was ₹85.2 Lakh. Net profit was ₹55,431 (1% margin). EBITDA was ₹76,700 (1% margin).

  • ₹85.2 LakhRevenue · FY 2025
  • ₹55,431Net profit · 1% margin
  • ₹76,700EBITDA · 1% margin
  • ₹15 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Wishco Global Private Limited are on its company page.

Premium access

Detailed financial statements for wiscoglobal

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about wiscoglobal

wiscoglobal was founded in 2024.

The primary company behind wiscoglobal, Wishco Global Private Limited, reported revenue of β‚Ή85.2 Lakh for FY 2025.

Wishco Pharma, a division of Wishco Global Pvt. Ltd., specializes in developing and distributing high-quality pharmaceuticals that meet international standards. The company focuses on therapeutic areas like antiviral and cardiovascular drugs, partnering with global innovators for in-licensing and out-licensing. Based in Bikaner, India, it facilitates trading, global sourcing, and tenders to address healthcare needs worldwide, ensuring affordable and reliable solutions for providers and patients.

wiscoglobal offers Azicocin 500, Ciprowish, CoughCure, Flucare, and Carbowish Injection.

wiscoglobal operates through Wishco Global Private Limited.

The legal entities of wiscoglobal currently have 2 directors, including Vaibhav Agarwal, Kanti Kamal Agarwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available